1. X
  2. Ovid C. Amadi
Log inSign up
Ovid C. Amadi
9,253 posts
Image
user avatar
Ovid C. Amadi
@Ovid_ARK
Multiomics Portfolio Manager and Director of Research @ARKinvest focused on biotech, diagnostics, and life science research Disclosure: arkinv.st/terms
ark-invest.com
Joined December 2013
1,450
Following
43.2K
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Oct 8, 2021
    The only place in #Tampabay that you need a sweatshirt ⁦@ARKInvest⁩ @CathieDWood⁩ #gobolts #tampabaylightning
    Image
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Oct 3, 2021
    At the University of Tokyo, @hnisimasu and Osamu Nureki used high-speed atomic force microscopy to document CRISPR Cas9 grasping the DNA and causing a DSB. To be able to actually see what CRISPR does is pretty remarkable. Happy Sunday!
    user avatar
    hnisimasu
    @hnisimasu
    Nov 10, 2017
    Single-molecule movie of DNA search and cleavage by CRISPR-Cas9.
    Image
    GIF
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Jul 29, 2021
    I spy with my little eye Pfizer's mRNA strategy! This highlights the company's plan to go after internal medicine and rare diseases with base editing. Source:s21.q4cdn.com/317678438/file…
    Image
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Mar 18, 2021
    mRNA is one of the most important innovations of 2020/2021 because of the current pandemic. mRNA is thought to be an ideal vaccine technology for SARS-CoV-2 which is an RNA virus. What is the future for mRNA? Thanks @VoicesofWallSt and @miketeich01 for the collaboration!
    user avatar
    Voices of Wall Street 🗣
    @VoicesofWallSt
    Mar 18, 2021
    mRNA is a game-changing innovation for healthcare & creates a major investment opportunity for companies w/ pipelines across infectious diseases, rare diseases, & oncology @aurmanARK @ARKInvest breaks down the mRNA investment opportunity in 5 min WATCH: youtu.be/X0AXNCTNfgE
    Image
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Feb 1, 2021
    The long awaited mRNA podcast is live! I am delighted to announce that we interviewed @sbancel and Joseph Payne, CEOs of @moderna_tx and @ArcturusRx.
    Image
    Understanding mRNA | Podcast with Moderna and Arcturus Therapeutics
    From ark-invest.com
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Nov 10, 2020
    The first patient was dosed with in vivo CRISPR gene editing therapy! Big day for gene editing!
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Jun 27, 2021
    Today, @intelliatweets announced data from its ongoing phase I trial for NTLA-2001 in Hereditary Transthyretin Amyloidosis (hATTR). This was monumental because it is the first data demonstrating the safety and efficacy of in vivo CRISPR Cas9 genome editing in humans.
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Jan 10, 2022
    Replying to @Ovid_ARK
    If you take the top 1% (300) and assign a $100 mn up front cash payment to each, that is $30B potential revenue just in upfront cash.
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Jan 10, 2022
    At the JP Morgan Healthcare Conference M&A was scarce, but gene editing collaborations and enthusiasm, were aplenty! Consider this: there are 30,000 pathogenic transition mutations that can be fixed with base editing.
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Dec 9, 2021
    Virus RNA, which can be detected in sewer water is a potential indicator of future COVID (SARS-CoV-2) infections. If that's the case and these charts are correct, we may see an uptick in the coming weeks of confirmed cases. Source: mwra.com/biobot/biobotd…
    Image
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Jan 26, 2021
    Looking forward to sharing #Bigideas2021. What do you think will be our focus/outlook for genomics this year? Any predictions?
    user avatar
    ARK Invest
    @ARKInvest
    Jan 26, 2021
    What areas are we most excited about for 2021? Find out later 𝐓𝐎𝐃𝐀𝐘 in our #BigIdeas2021 report.
    Image
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Apr 5, 2022
    We believe that AlphaFold and other neural network-based algorithms could lower pre-clinical trial costs and invigorate drug candidate pipelines.
    user avatar
    ARK Invest
    @ARKInvest
    Apr 5, 2022
    We believe current early-stage clinical trial pipelines, which growth equity investors often neglect, will be more valuable than many realize. Don't miss our brand new blog by Analyst @aurmanARK! arkinv.st/3DFTDug
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Feb 15, 2022
    I'm doing a deep dive on psychedelics. If anyone has any good resources to share, please do! I'm also working on a podcast, so if anyone has any burning questions, let me know!
  • user avatar
    Ovid C. Amadi
    @Ovid_ARK
    Sep 16, 2021
    Check out my Medium post on the different modalities of #geneediting, including #CRISPR Cas9/Cas12a, #baseediting, and #primeediting. medium.com/p/gene-editing…
Advertisement
Advertisement